AU2021900506A0 - Peptides and their use in diagnosis of SARS-CoV-2 infection - Google Patents

Peptides and their use in diagnosis of SARS-CoV-2 infection

Info

Publication number
AU2021900506A0
AU2021900506A0 AU2021900506A AU2021900506A AU2021900506A0 AU 2021900506 A0 AU2021900506 A0 AU 2021900506A0 AU 2021900506 A AU2021900506 A AU 2021900506A AU 2021900506 A AU2021900506 A AU 2021900506A AU 2021900506 A0 AU2021900506 A0 AU 2021900506A0
Authority
AU
Australia
Prior art keywords
cov
sars
peptides
infection
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021900506A
Inventor
Alma Fulurija
Ali Mohaghegh Harandi
Bror Samuel LUNDIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotome Pty Ltd
Vivocens AB
Original Assignee
Biotome Pty Ltd
Vivocens AB
Filing date
Publication date
Application filed by Biotome Pty Ltd, Vivocens AB filed Critical Biotome Pty Ltd
Publication of AU2021900506A0 publication Critical patent/AU2021900506A0/en
Priority to CA3211678A priority Critical patent/CA3211678A1/en
Priority to PCT/AU2022/050153 priority patent/WO2022178591A1/en
Priority to EP22758644.3A priority patent/EP4298113A1/en
Priority to AU2022226004A priority patent/AU2022226004A1/en
Pending legal-status Critical Current

Links

AU2021900506A 2021-02-24 2021-02-24 Peptides and their use in diagnosis of SARS-CoV-2 infection Pending AU2021900506A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA3211678A CA3211678A1 (en) 2021-02-24 2022-02-24 Peptides and their use in diagnosis of sars-cov-2 infection
PCT/AU2022/050153 WO2022178591A1 (en) 2021-02-24 2022-02-24 Peptides and their use in diagnosis of sars-cov-2 infection
EP22758644.3A EP4298113A1 (en) 2021-02-24 2022-02-24 Peptides and their use in diagnosis of sars-cov-2 infection
AU2022226004A AU2022226004A1 (en) 2021-02-24 2022-02-24 Peptides and their use in diagnosis of sars-cov-2 infection

Publications (1)

Publication Number Publication Date
AU2021900506A0 true AU2021900506A0 (en) 2021-03-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP4112648A4 (en) Anti-sars-cov-2 infection protein and vaccine
EP4095148A4 (en) Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof
EP4019530A4 (en) Peptide having activity of improving skin condition and use thereof
EP4119162A4 (en) Pvrig binding protein and its medical uses
EP3744335A4 (en) Medicinal preparation and medical instrument
GB202210382D0 (en) Primer and probe sets for pathogen detection of infection in transplant patient, kit and use thereof
EP3800193A4 (en) Peptide having skin whitening activity and use thereof
EP3915985A4 (en) Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease
EP4048298A4 (en) Preparation and use of therapeutic hydrogels
IL285171A (en) Treatment of skin lesions and pruritus in prurigo nodularis patients
EP4121118A4 (en) Nano-delivery system and therapeutic and diagnostic use thereof
EP4101449A4 (en) Application of nitazoxanide and active form thereof, tizoxanide, in treatment of sars-cov-2 infection
EP4190344A4 (en) Use of polypeptide in preparation of wound treatment drug
AU2021900506A0 (en) Peptides and their use in diagnosis of SARS-CoV-2 infection
EP3945093A4 (en) Synthetic peptide brap and use thereof in preparation of anti-inflammatory medicine for covid-19
EP4072456A4 (en) Tissue mapping and treatment
EP4003355A4 (en) Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases
EP3800194A4 (en) Peptide having skin whitening activity and use thereof
EP4067504A4 (en) Use of synaptotagmin-7 in the diagnosis and treatment of bipolar disorder
AU2021900616A0 (en) Peptides and their use in diagnosis
AU2021900617A0 (en) Peptides and their use in diagnosis
AU2020900885A0 (en) Peptides and their use in diagnosis
AU2020900887A0 (en) Peptides and their use in diagnosis
EP4031174A4 (en) Human anti-pd-l1 peptide vaccines and methods of their use
AU2023902106A0 (en) Peptides and Their Use in Diagnosis